Nutritional Problems After Lung and Heart Transplantation

NCT00826254 — Not applicable, Unknown, 94 participants, Oslo University Hospital
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT00826254
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: quadruple, prevention
Enrollment94 (Actual)
SponsorOslo University Hospital (Other); collaborators: Norwegian Foundation for Health and Rehabilitation
ConditionsBone Density, Overweight
InterventionsVitamin K (Drug)
Datesstart 2003-08-01, primary completion 2007-04-01, completion 2011-12-01 (estimated), first posted 2009-01-22, last updated 2011-07-06
Locations1 site in Norway

Related Papers Related Patents Related Grants Related Experts
All trials for Bone Density All trials for Overweight All trials of Vitamin K

-Summary

Part 1) Bone health after transplantation - possible influence of vitamin K

Part 2) Fat metabolism and endocrine parameters - possible predictors for developement of overweight after transplantation

Expand all sections  ·  Collapse all

+Arms and interventions

  • Vitamin K (Drug), also known as Natto: 180 micrograms vitamin K daily
  • Vitamin K (Drug), also known as Natto: 2 capsules daily 180 micrograms vitamin K daily or placebo 1 year

+Outcome measures

Primary outcomes

  • plasma vitamin K [1 year]

Secondary outcomes

  • Bone mineral density [1 year]

+Eligibility

Sex: All, ages: 20 Years to 70 Years

Inclusion Criteria:

* accepted for transplantation

Exclusion Criteria:

* not accepted for transplantation

+Locations (1)

FacilityCityCountryStatus
Rikshospitalet HFOslo, OsloNorway

+Investigators